{
  "docId": "019de516-01ce-701d-bd9b-acac15fa9fab",
  "docSlug": "a13be9775a99db49a0c5c2ac3ee2ea88",
  "documentTitle": "Oculis | Investor Conference Presentation Deck | 39 slides",
  "authorId": "oculis",
  "authorName": "Oculis",
  "documentKindSlug": "conference-presentation",
  "documentKindLabel": "Conference presentation",
  "sourceTypeSlug": "investor_relations",
  "sourceTypeLabel": "Investor relations",
  "presentationDate": "2023-06-01 00:00:00",
  "orientation": "landscape",
  "aspectRatio": 1.7777778,
  "pageNumber": 38,
  "pageCount": 39,
  "prevPage": 37,
  "nextPage": 39,
  "slideType": "roadmap",
  "function": "plan_implementation",
  "density": "overcrowded",
  "nDataPoints": 0,
  "notes": null,
  "elementsJson": null,
  "metadataConfidence": 1,
  "imagePath": null,
  "slideHref": "/slides/019de516-01ce-701d-bd9b-acac15fa9fab/38",
  "deckHref": "/decks/019de516-01ce-701d-bd9b-acac15fa9fab",
  "deckJsonHref": "/decks/019de516-01ce-701d-bd9b-acac15fa9fab.json",
  "deckAnchorHref": "/decks/019de516-01ce-701d-bd9b-acac15fa9fab#slide-38",
  "components": [
    {
      "bbox": {
        "h": 0.02,
        "w": 0.37,
        "x": 0.08,
        "y": 0.53
      },
      "kind": "list",
      "text": "Q3: OCS-01 Ocular Surgery Phase 3 readout",
      "attrs": null,
      "subkind": "timeline-item",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "08eea4c6-af48-4986-9e69-14711e1f9949",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.02,
        "w": 0.35,
        "x": 0.08,
        "y": 0.46
      },
      "kind": "list",
      "text": "OCS-01 DME Phase 3 (Stage 1) readout",
      "attrs": null,
      "subkind": "timeline-item",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "5816418b-da95-4134-96da-a87f45d04f18",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.02,
        "w": 0.28,
        "x": 0.63,
        "y": 0.6
      },
      "kind": "list",
      "text": "2H: OCS-02 Uveitis Ph 2b readout",
      "attrs": null,
      "subkind": "timeline-item",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "7b2acabf-1f34-4966-876f-b228836e426a",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.02,
        "w": 0.28,
        "x": 0.63,
        "y": 0.46
      },
      "kind": "list",
      "text": "2H: OCS-02 DED (1) Ph 2b readout",
      "attrs": null,
      "subkind": "timeline-item",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "7d3350e3-5db3-4f1e-8086-c6d2e5cf64ae",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.02,
        "w": 0.28,
        "x": 0.63,
        "y": 0.74
      },
      "kind": "list",
      "text": "Q4: OCS-01 Ocular Surgery NDA",
      "attrs": null,
      "subkind": "timeline-item",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "aae330d0-edaf-48e9-a02f-ea3aa9ee32d2",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.02,
        "w": 0.32,
        "x": 0.63,
        "y": 0.53
      },
      "kind": "list",
      "text": "2H: OCS-01 CME(2) Ph 2 PoC (3) readout",
      "attrs": null,
      "subkind": "timeline-item",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "ade33356-96f6-436a-abcb-ecc85f398ac6",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.15,
        "w": 0.28,
        "x": 0.65,
        "y": 0.25
      },
      "kind": "list",
      "text": "2024: Up to 4 clinical readouts expected in 2024 & NDA",
      "attrs": null,
      "subkind": "timeline-item",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "c4655540-f6b7-4b02-a94c-ad71bfc4ba6f",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.15,
        "w": 0.3,
        "x": 0.11,
        "y": 0.25
      },
      "kind": "list",
      "text": "2023: One additional Phase 3 readout expected in 2023",
      "attrs": null,
      "subkind": "timeline-item",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "d3a318de-633e-4c04-b3df-18cda6271ea7",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.02,
        "w": 0.32,
        "x": 0.63,
        "y": 0.67
      },
      "kind": "list",
      "text": "2H: OCS-05 AON(4) Ph 2 PoC(3) readout",
      "attrs": null,
      "subkind": "timeline-item",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "e07a4dd5-ddd8-408b-b7a6-7482a8a1c1d7",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.07,
        "w": 0.19,
        "x": 0.05,
        "y": 0.89
      },
      "kind": "source-note",
      "text": "(1) Dry Eye Disease (DED)\n(2) Cystoid Macular Edema (CME).\n(3) Proof-of-concept (PoC)\n(4) Acute Optic Neuritis (AON)",
      "attrs": null,
      "subkind": null,
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "5e9aa33e-6d2c-4ea0-adf6-9243569186a9",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.02,
        "w": 0.69,
        "x": 0.025,
        "y": 0.12
      },
      "kind": "title",
      "text": "Adequately capitalized with anticipated cash runway into 2026",
      "attrs": null,
      "subkind": "action-title",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "d533310c-24ed-4e60-988f-0f3536e7da39",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.05,
        "w": 0.84,
        "x": 0.025,
        "y": 0.067
      },
      "kind": "title",
      "text": "Two Phase 3 & Four Additional Readouts Expected in 2023 & 2024",
      "attrs": null,
      "subkind": "headline",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "05aa948e-b427-4b5c-822f-3c1e381888a2",
      "frameworkName": null,
      "frameworkSlug": null
    }
  ],
  "metrics": [],
  "tools": [],
  "frameworks": [],
  "arcBeats": [
    {
      "to": 39,
      "from": 25,
      "beatId": "6cce666b-f795-4a3e-a589-afe2a7266ece",
      "arcName": "The Consultant's Gambit",
      "arcSlug": "consultants-gambit",
      "beatName": "Impact & Next Steps",
      "beatSlug": "consultants-gambit-impact-next-steps",
      "evidence": "Slides 25-39 discuss OCS-02, OCS-05, and the track record of efficient capital deployment.",
      "position": 4,
      "confidence": 0.8,
      "parentBeatName": "Resolution",
      "parentBeatSlug": "resolution"
    }
  ],
  "loops": [],
  "imagePathAlt": null,
  "thumbSrc": null,
  "thumbSrcAlt": null,
  "locked": true
}